Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bioartificial liver systems: current status and future perspective.

Jung-Keug Park1, Doo-Hoon Lee

  • 1Department of Chemical and Biochemical Engineering, Dongguk University, 3-26 Pil-dong, Choong-gu, Seoul 100-715, Korea. jkpark@dongguk.edu

Journal of Bioscience and Bioengineering
|October 20, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

"Off-The-Shelf" Bioartificial Liver Support System Using Cryopreserved Immobilized Hepatocyte Spheroids in a Porcine Acute Liver Failure Model.

Artificial organs·2025
Same author

Selecting serum-free hepatocyte cryopreservation stage and storage temperature for the application of an "off-the-shelf" bioartificial liver system.

Scientific reports·2024
Same author

Establishment of a Serum-Free Hepatocyte Cryopreservation Process for the Development of an "Off-the-Shelf" Bioartificial Liver System.

Bioengineering (Basel, Switzerland)·2022
Same author

Enhancement of osseointegration of artificial ligament by nano-hydroxyapatite and bone morphogenic protein-2 into the rabbit femur.

Tissue engineering and regenerative medicine·2019
Same author

Pigmentation effect of electromagnetic fields at various intensities to melanocytes.

Tissue engineering and regenerative medicine·2019
Same author

B7‑H1‑mediated immunosuppressive properties in human mesenchymal stem cells are mediated by STAT‑1 and not PI3K/Akt signaling.

Molecular medicine reports·2018

Bioartificial liver (BAL) devices using viable hepatocytes offer essential functions for acute liver failure. Despite safety advancements, a recent trial showed limited efficacy, highlighting the need for improved bioreactor design and cell sources.

Area of Science:

  • Hepatology and Regenerative Medicine
  • Biomedical Engineering
  • Artificial Organ Development

Background:

  • Acute liver failure (ALF) necessitates comprehensive metabolic support beyond simple detoxification.
  • Early artificial liver devices lacked the multifaceted functions of a healthy liver.
  • Bioartificial liver (BAL) systems, utilizing viable hepatocytes, emerged as a promising alternative.

Purpose of the Study:

  • To review current bioartificial liver systems for acute liver failure management.
  • To discuss critical challenges in BAL development, including bioreactor design and cell sourcing.
  • To explore future perspectives for BAL technology, integrating stem cell advancements.

Main Methods:

  • Review of nine reported clinical studies on various BAL systems since 1990.

Related Experiment Videos

  • Analysis of hollow fiber technology prevalence in existing BAL designs.
  • Discussion of safety considerations (immunological reactions, zoonosis, tumorgenicity) and efficacy trials.

    • Main Results:

    • Multiple BAL systems have been developed, with many employing hollow fiber technology.
    • Safety concerns have been addressed, facilitating regulatory approval for some systems.
    • A major Phase III trial of a leading BAL system (HepatAssist) did not meet efficacy expectations for survival rates.

    Conclusions:

    • While safety has improved, the clinical efficacy of current BAL systems remains a significant challenge.
    • Optimizing bioreactor configuration and exploring novel hepatocyte sources (e.g., stem cells) are crucial for future BAL development.
    • Continued research is essential to realize the full therapeutic potential of bioartificial liver technology in treating acute liver failure.